These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3783172)

  • 1. The distribution of multiple sclerosis in the United Kingdom.
    Swingler RJ; Compston D
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1115-24. PubMed ID: 3783172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology.
    Forbes RB; Swingler RJ
    Am J Epidemiol; 1999 Jun; 149(11):1016-24. PubMed ID: 10355377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.
    Dean G; Goodall J; Downie A
    J Epidemiol Community Health; 1981 Jun; 35(2):110-3. PubMed ID: 7299334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA and multiple sclerosis in south east Wales.
    Swingler RJ; Kirk PF; Darke C; Compston DA
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality rates from multiple sclerosis: geographical and temporal variations revisited.
    Williams ES; Jones DR; McKeran RO
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):104-9. PubMed ID: 2019834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis.
    Hely MA; McManis PG; Doran TJ; Walsh JC; McLeod JG
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1125-30. PubMed ID: 3783173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.
    Poskanzer DC; Prenney LB; Sheridan JL; Kondy JY
    J Epidemiol Community Health; 1980 Dec; 34(4):229-39. PubMed ID: 7241022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.
    Robertson N; Deans J; Fraser M; Compston DA
    J Epidemiol Community Health; 1996 Jun; 50(3):274-9. PubMed ID: 8935458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and multiple sclerosis in Northern Ireland.
    Hawkins SA; Cullen C; Middleton D; Morrow JI
    Ir J Med Sci; 1990 Mar; 159(3):68-70. PubMed ID: 2361821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up.
    Francis DA; Compston DA; Batchelor JR; McDonald WI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):758-65. PubMed ID: 3497228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens and multiple sclerosis in the Province of Ferrara, northern-Italy: a community-based study.
    Casetta I; Granieri E; Conighi C; Grappa MT; Tola MR; Govoni V; Paolino E; Mattiuz PL; Carreras M
    Riv Neurol; 1991; 61(1):12-6. PubMed ID: 1857917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of multiple sclerosis in south east Wales.
    Swingler RJ; Compston DA
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1520-4. PubMed ID: 3265431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.
    Sharpe G; Price SE; Last A; Thompson RJ
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):22-6. PubMed ID: 7823062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No apparent association between HLA and multiple sclerosis in southern Chinese.
    Hawkins BR; Yu YL; Woo E; Huang CY
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):443-5. PubMed ID: 3162954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.
    Rothwell PM; Charlton D
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):730-5. PubMed ID: 9647300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.